A detailed history of Frontier Capital Management CO LLC transactions in Dexcom Inc stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 735,926 shares of DXCM stock, worth $55.8 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
735,926
Previous 743,037 0.96%
Holding current value
$55.8 Million
Previous $84.2 Million 41.46%
% of portfolio
0.49%
Previous 0.88%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $455,104 - $825,302
-7,111 Reduced 0.96%
735,926 $49.3 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $3.52 Million - $4.49 Million
-31,948 Reduced 4.12%
743,037 $84.2 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $2.09 Million - $2.56 Million
-18,287 Reduced 2.31%
774,985 $107 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $25.8 Million - $42.5 Million
342,075 Added 75.81%
793,272 $98.4 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $21.9 Million - $35.1 Million
-254,773 Reduced 36.09%
451,197 $42.1 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $2.66 Million - $3.1 Million
-23,682 Reduced 3.25%
705,970 $90.7 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $3.6 Million - $4.25 Million
34,592 Added 4.98%
729,652 $84.8 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $3.83 Million - $5.53 Million
45,110 Added 6.94%
695,060 $78.7 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1.96 Million - $2.42 Million
-25,643 Reduced 3.8%
649,950 $52.3 Million
Q2 2022

Jul 20, 2022

BUY
$67.99 - $132.89 $33.2 Million - $64.9 Million
488,749 Added 261.58%
675,593 $50.4 Million
Q1 2022

Apr 14, 2022

SELL
$94.08 - $130.2 $2.57 Million - $3.56 Million
-27,338 Reduced 12.76%
186,844 $95.6 Million
Q4 2021

Jan 19, 2022

SELL
$129.87 - $162.82 $6.15 Million - $7.71 Million
-47,362 Reduced 18.11%
214,182 $115 Million
Q3 2021

Oct 19, 2021

BUY
$106.71 - $143.18 $7.1 Million - $9.52 Million
66,493 Added 34.09%
261,544 $143 Million
Q2 2021

Aug 09, 2021

BUY
$80.99 - $107.93 $2.32 Million - $3.1 Million
28,696 Added 17.25%
195,051 $83.3 Million
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $5.38 Million - $6.64 Million
-63,399 Reduced 27.59%
166,355 $59.8 Million
Q4 2020

Jan 19, 2021

BUY
$78.0 - $104.5 $906,360 - $1.21 Million
11,620 Added 5.33%
229,754 $84.9 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $7.14 Million - $8.45 Million
-74,769 Reduced 25.53%
218,134 $89.9 Million
Q2 2020

Jul 17, 2020

SELL
$62.68 - $105.34 $7.55 Million - $12.7 Million
-120,378 Reduced 29.13%
292,903 $119 Million
Q1 2020

Apr 16, 2020

SELL
$47.79 - $75.63 $4.02 Million - $6.37 Million
-84,181 Reduced 16.92%
413,281 $111 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $6.14 Million - $9.6 Million
167,648 Added 50.83%
497,462 $109 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $2.35 Million - $2.89 Million
-66,064 Reduced 16.69%
329,814 $49.2 Million
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $2.26 Million - $3.16 Million
81,145 Added 25.78%
395,878 $59.3 Million
Q1 2019

May 07, 2019

SELL
$28.07 - $38.18 $1.44 Million - $1.95 Million
-51,176 Reduced 13.99%
314,733 $37.5 Million
Q4 2018

Jan 25, 2019

SELL
$26.99 - $37.37 $1.64 Million - $2.28 Million
-60,905 Reduced 14.27%
365,909 $43.8 Million
Q3 2018

Oct 30, 2018

SELL
$23.35 - $36.72 $5.51 Million - $8.66 Million
-235,762 Reduced 35.58%
426,814 $61.1 Million
Q2 2018

Aug 03, 2018

SELL
$17.54 - $25.22 $3.3 Million - $4.75 Million
-188,318 Reduced 22.13%
662,576 $62.9 Million
Q1 2018

Apr 30, 2018

BUY
$13.06 - $18.54 $2.13 Million - $3.02 Million
162,737 Added 23.65%
850,894 $63.1 Million
Q4 2017

Jan 18, 2018

SELL
$11.12 - $15.38 $1.78 Million - $2.47 Million
-160,513 Reduced 18.91%
688,157 $39.5 Million
Q3 2017

Oct 31, 2017

BUY
$11.36 - $18.98 $9.64 Million - $16.1 Million
848,670
848,670 $41.5 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.